SPECIMEN · BATCH IP10
HPLC TESTED
Ipamorelin 10mg
FormLyophilised powder
Content10 mg / vial
CAS170851-70-4
Purity≥97.5% (HPLC)
✓ HPLC TESTED · BATCH IP10IN STOCK · SHIPS NEXT BUSINESS DAY
GH Secretagogues / GHRP

Ipamorelin10 mg

Selective GH secretagogue (GHRP).

$85.00≈ $8.50 / mg
$72.25 WITH BITCOIN

Quantity

1custom quantity
Included with this compoundBAC Water 3 mL · 1 vial per peptideFREE

One 3 mL vial of bacteriostatic water is packed free with every peptide vial and added to your order automatically. It is a diluent, not a second peptide.

0.9% benzyl alcohol limits microbial growth in solution. No receptor activity. Research use only.

BUY MORE, PAY LESSMIX & MATCH ANY PEPTIDES
1–9$85.00per vial
10+$76.50−10%
15+$68.00−20%
20+$63.75−25%
30+$51.00−40%

Pay with Bitcoin for an extra −15% on top — e.g. 20+ vials: $51.00 each. Final price is confirmed at checkout.

For laboratory research use only. Not for human or animal consumption.

ENCRYPTED CHECKOUT · LAB VERIFIED

Order within 0h 0m - ships today

Cutoff 3:00 PM ET

WINDOW OPEN

Calculating delivery estimate...

Free standard shipping on orders over $200

Shipped in protected packaging

Anti-breakage box, double-cushioned for you

DOCUMENT RACK · BATCH IP10

Every document for this exact batch.

4 OF 4 ON FILE · INDEPENDENT LAB · EU

About Ipamorelin

What is Ipamorelin?

Ipamorelin (CAS 170851-70-4) is a synthetic pentapeptide growth-hormone secretagogue. It binds the ghrelin receptor (GHS-R / GHRP receptor) and is used when a lab needs a selective GH-axis stimulus rather than an older, less selective GHRP.

Werhner Lab supplies ipamorelin as lyophilised powder in 10 mg vials.

CAS: 170851-70-4. Molecular weight: ~711.9 g/mol. Target: GHS-R.

How Ipamorelin is studied in the literature

Papers describe ipamorelin as a selective ghrelin-mimetic used in pituitary and GH-release models. The notes below are research background only.

GH-axis and pituitary signalling

Used to study growth-hormone release cascades with less off-target movement of cortisol and ACTH than GHRP-2 or GHRP-6 in many published comparisons.

Receptor selectivity models

Chosen when the design needs GHS-R activation without a strong appetite or prolactin signal.

Within the GH-secretagogue class — how Ipamorelin differs

FeatureGHRP-2 / GHRP-6IpamorelinTesamorelin
Main targetGHS-R (less selective)GHS-R (more selective)GHRH receptor
LengthShort peptide5 amino acidsGHRH analogue (long)
Typical research angleBroad GH pulse + more side signalsCleaner GHS-R modelUpstream hypothalamic-style signal

Ipamorelin does not replace a GHRH analogue. It works at a different receptor.

Research areas

  • Ghrelin-receptor binding and signalling
  • Pituitary GH-release models
  • Selectivity versus first-generation GHRPs
  • Combination designs with GHRH analogues (separate compounds)

Specifications

CAS170851-70-4
Molecular weight~711.9 g/mol
Receptor profileGHS-R agonist (secretagogue)
Purity≥ 97.5% (batch CoA)
FormLyophilised powder, sealed vial
Size10 mg

Storage

Powder: −20°C long term; 2–8°C short term.

Reconstituted: 2–8°C; follow lab SOP. Avoid repeat freeze–thaw.

Quality

Batch CoA on request. Batch example: IP10-9014.

Important notice — Research Use Only

Ipamorelin is supplied by Werhner Lab for laboratory research only. Literature notes are background, not medical claims. Not a medicine or supplement. Not for human consumption.